slides · global inventory
Analyze Data
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 58,039
Current window 40,081-40,110
Pages 1,935
Rows per page 30
Slide function
40,081-40,110 of 58,039
10
Includes a disclaimer about GAAP/non-GAAP reconciliation.FGI Industries | Investor Presentation Deck | 15 slides · FGI Industries
Pitch deck Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
11
Includes a disclaimer regarding the basis of the guidance and specific investment costs.FGI Industries | Investor Presentation Deck | 15 slides · FGI Industries
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
13
Reconciliation of GAAP income from operations to adjusted income from operations.FGI Industries | Investor Presentation Deck | 15 slides · FGI Industries
Pitch deck Investor relations 1 hit
15
FGI Industries | Investor Presentation Deck | 15 slidesFGI Industries | Investor Presentation Deck | 15 slides · FGI Industries
Pitch deck Investor relations 1 hit
23
Includes footnotes for non-GAAP measures and cash definition.FiscalNote | Investor Presentation Deck | 33 slides · FiscalNote
Pitch deck Investor relations Beat · Financials1 hit
25
Includes specific footnotes regarding non-GAAP measures and run-rate revenue definitions.FiscalNote | Investor Presentation Deck | 33 slides · FiscalNote
Pitch deck Investor relations Beat · Financials1 hit
29
Contains two distinct financial tables for non-GAAP reconciliation.FiscalNote | Investor Presentation Deck | 33 slides · FiscalNote
Pitch deck Investor relations 1 hit
30
Includes detailed footnotes (a-g) explaining specific adjustments.FiscalNote | Investor Presentation Deck | 33 slides · FiscalNote
Pitch deck Investor relations 1 hit
31
The table uses the treasury stock method to calculate dilution based on different price points from $2.08 to $25.00.FiscalNote | Investor Presentation Deck | 33 slides · FiscalNote
Pitch deck Investor relations 1 hit
23
The table includes metrics for transactions, GBV, revenue, and adjusted EBITDA with year-over-year growth projections.Freightos | Investor Presentation Deck | 34 slides · Freightos
Pitch deck Investor relations Beat · Financials1 hit
24
Freightos | Investor Presentation Deck | 34 slidesFreightos | Investor Presentation Deck | 34 slides · Freightos
Pitch deck Investor relations Beat · Financials1 hit
28
The table includes a specific line item for 'Share listing expense' which is footnoted as a non-recurring, non-cash expense.Freightos | Investor Presentation Deck | 34 slides · Freightos
Pitch deck Investor relations 1 hit
29
The table provides a clear bridge between GAAP/IFRS operating loss and non-GAAP Adjusted EBITDA metrics.Freightos | Investor Presentation Deck | 34 slides · Freightos
Pitch deck Investor relations 1 hit
30
The table shows adjustments for share-based compensation and depreciation & amortization to arrive at non-IFRS metrics.Freightos | Investor Presentation Deck | 34 slides · Freightos
Pitch deck Investor relations 1 hit
31
Freightos | Investor Presentation Deck | 34 slidesFreightos | Investor Presentation Deck | 34 slides · Freightos
Pitch deck Investor relations 1 hit
32
The table shows adjustments for share-based compensation and depreciation & amortization.Freightos | Investor Presentation Deck | 34 slides · Freightos
Pitch deck Investor relations 1 hit
33
Freightos | Investor Presentation Deck | 34 slidesFreightos | Investor Presentation Deck | 34 slides · Freightos
Pitch deck Investor relations 1 hit
11
The slide uses a waterfall chart to explain the cash position change.Freyr | Results Presentation Deck | 14 slides · FREYR
Conference presentation Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
17
The chart shows FPI-1434 Plasma AUC for two different dosing regimens.Fusion Pharmaceuticals | Investor Presentation Deck | 30 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
25
The slide presents clinical trial data comparing pharmacokinetics and safety (thrombocytopenia) profiles.Fusion Pharmaceuticals | Investor Presentation Deck | 30 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
26
Includes specific highlighting boxes (green, yellow, red) around data subsets.Fusion Pharmaceuticals | Investor Presentation Deck | 30 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
27
Includes SPECT/CT imaging evidence and dosimetric data tables.Fusion Pharmaceuticals | Investor Presentation Deck | 30 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
23
The slide highlights the difference between standard IFRS reporting and adjusted non-IFRS metrics.Gogoro | Investor Presentation Deck | 30 slides · Gogoro
Pitch deck Investor relations 1 hit
28
The slide presents two distinct tables for different time periods (3 months vs 9 months) to reconcile IFRS revenue to constant currency revenue.Gogoro | Investor Presentation Deck | 30 slides · Gogoro
Pitch deck Investor relations 1 hit
29
Standard financial disclosure slide for non-GAAP/non-IFRS reconciliation.Gogoro | Investor Presentation Deck | 30 slides · Gogoro
Pitch deck Investor relations 1 hit
30
Gogoro | Investor Presentation Deck | 30 slidesGogoro | Investor Presentation Deck | 30 slides · Gogoro
Pitch deck Investor relations 1 hit
07
Includes a footnote regarding non-GAAP measures.Hagerty | Investor Presentation Deck | 18 slides · Hagerty
Conference presentation Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
08
The slide uses stacked bar charts to show revenue composition and growth rates across three segments: Commission + fee, Membership/marketplace, and Earned premium.Hagerty | Investor Presentation Deck | 18 slides · Hagerty
Conference presentation Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
09
The slide uses a dual-chart visual for Net Income and Adjusted EBITDA alongside a detailed reconciliation table for Adjusted EBITDA.Hagerty | Investor Presentation Deck | 18 slides · Hagerty
Conference presentation Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
10
The table compares current 2023 outlook ranges against prior Q2 2023 outlook ranges.Hagerty | Investor Presentation Deck | 18 slides · Hagerty
Conference presentation Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit